Adlai Nortye Ltd. Files 2024 Annual Report

Ticker: ANL · Form: 20-F · Filed: Apr 30, 2025 · CIK: 1944552

Sentiment: neutral

Topics: annual-report, 20-f, pharmaceuticals

TL;DR

Adlai Nortye filed its 2024 20-F, check it for biz updates.

AI Summary

Adlai Nortye Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, operating in the pharmaceutical preparations sector, is based in North Brunswick, NJ, and incorporated in Delaware. This filing serves as an annual report, not a registration statement or transition report.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Adlai Nortye Ltd.'s financial performance and business operations for the fiscal year 2024.

Risk Assessment

Risk Level: low — This filing is a standard annual report and does not contain immediate, high-impact disclosures.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this filing?

This filing is an annual report on Form 20-F for the fiscal year ended December 31, 2024, as required by Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is Adlai Nortye Ltd.'s industry classification?

Adlai Nortye Ltd. is classified under Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.

Where is Adlai Nortye Ltd. located?

The company's business and mail address is located at 685 U.S. Highway One, 2nd Floor, North Brunswick, NJ 08902.

When was this Form 20-F filed?

This Form 20-F was filed on April 30, 2025.

What is the company's state of incorporation?

Adlai Nortye Ltd. is incorporated in Delaware (DE).

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on April 30, 2025 regarding Adlai Nortye Ltd. (ANL).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing